Home > Boards > US Listed > Biotechs > Regeneron Pharmaceuticals (REGN)

EPS = 11.27

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TREND1 Member Profile
Member Level 
Followed By 412
Posts 54,780
Boards Moderated 22
Alias Born 12/16/01
160x600 placeholder
Regeneron Gets FDA Priority Review of Evinacumab Dow Jones News - 8/12/2020 8:01:00 AM
FDA Accepts Evinacumab Biologics License Application for Priority Review as a Treatment for Patients with HoFH, an Ultra-rare... PR Newswire (US) - 8/12/2020 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/11/2020 6:05:29 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 8/7/2020 4:49:31 PM
Regeneron Announces Pricing of Public Offering of Senior Unsecured Notes PR Newswire (US) - 8/7/2020 4:05:00 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/7/2020 9:28:43 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2020 5:11:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2020 5:09:30 PM
U.S. Stock Futures Edge Higher, Gold Rallies Dow Jones News - 8/5/2020 9:32:00 AM
U.S. Stock Futures Edge Higher, Gold Rallies Dow Jones News - 8/5/2020 9:04:00 AM
U.S. Stock Futures Edge Higher, Gold Rallies Dow Jones News - 8/5/2020 8:52:00 AM
U.S. Stock Futures Edge Higher, Gold Rallies Dow Jones News - 8/5/2020 8:17:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2020 7:37:59 AM
Regeneron 2Q Profit Surges on Collaborations Dow Jones News - 8/5/2020 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2020 7:16:12 AM
Regeneron Reports Second Quarter 2020 Financial and Operating Results PR Newswire (US) - 8/5/2020 6:30:00 AM
Rowley Law PLLC is Investigating Potential Breaches of Fiduciary Duty by Officers & Directors of Regeneron Pharmaceuti... Business Wire - 8/3/2020 8:30:00 AM
Teen Scientists Win $1.8 Million at Virtual Regeneron Science Talent Search 2020 for Exemplary Research on Predicting Crop Yi... PR Newswire (US) - 7/29/2020 10:25:00 PM
Teen Scientists Win $1.8 Million at Virtual Regeneron Science Talent Search 2020 for Exemplary Research on Predicting Crop Yi... PR Newswire (US) - 7/29/2020 9:00:00 PM
BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National Preparedness PR Newswire (US) - 7/29/2020 7:00:00 AM
WeissLaw LLP Investigates Regeneron Pharmaceuticals, Inc. PR Newswire (US) - 7/22/2020 8:20:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/22/2020 4:32:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/22/2020 4:31:07 PM
Vyriad Announces Initiation of Phase 2 Trial in Multiple Cancer Indications GlobeNewswire Inc. - 7/20/2020 10:00:10 AM
Kiniksa Gets FDA Orphan Designation for Rilonacept in Pericarditis Dow Jones News - 7/16/2020 8:14:00 AM
TREND1 Member Level  Monday, 09/24/18 07:36:18 PM
Re: None
Post # of 156 
EPS = 11.27

All my posts are just my opinions. I receive no compensation for
posts. These posts are for entertainment purposes only. I maybe
long or short or hold no position.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist